Vivien Mak

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

Vivien Mak, Jeremey Hamm, Mukesh Chhanabhai et al. · Journal of Clinical Oncology · 2013 · 428 citations · Full text

Medicine, Hematology, Oncology +15

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Harinder Gill, Rita Yim, Harold K. K. Lee et al. · Cancer · 2018 · 79 citations · Full text

Medicine, Hematology, Oncology +10

Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study

Harinder Gill, Cyrus R. Kumana, Rita Yim et al. · Cancer · 2019 · 55 citations · Full text

Medicine, Hematology, Oncology +15

Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008

Vivien Mak, Oscar Mang, Chinmay B. Dalal et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2013 · 35 citations

Medicine, Hematology, Oncology +16

Fibroblastic rheumatism: clinical and histologic evolution of cutaneous manifestations.

Adel G. Fam, Wedad Hanna, Vivien Mak et al. · PubMed · 1998 · 32 citations

Medicine, Dermatology, Pathology +17